Alwadani, BandarDall'Angelo, SergioFleming, Ian2021-07-052021-07-052021-07-02Alwadani, B, Dall'Angelo, S & Fleming, I 2021, 'Clinical value of 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancer', Insights into Imaging, vol. 12, no. 1, 90. https://doi.org/10.1186/s13244-021-01026-11869-4101ORCID: /0000-0001-9505-6418/work/96652404ORCID: /0000-0001-9377-0474/work/176747519https://hdl.handle.net/2164/16776Funding This review was supported by funding provided by the Royal Embassy of Saudi Arabia, Cultural Bureau in London, UK. We also gratefully acknowledge Friends of Anchor for their generous financial support of our research. Availability of data and materials The datasets used and/or analyses during the current study are available from the corresponding author upon reasonable request.211426949engSubstantive connection, author subsequently moved to an eligible contractSDG 3 - Good Health and Well-beingPositron emission tomographyPETLung cancerFluorothymidine[18F]FLTR MedicineRJournal article10.1186/s13244-021-01026-1121